secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001104659-23-069896
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics announces 2023 annual meeting voting results; all director nominees elected
--------------------------------------------------------------------------------

- Five director nominees elected with votes for ranging from 2,473,599 to 2,500,415; broker non-votes 3,193,097.
- Advisory approval of named executive officer compensation: 2,347,263 for, 321,791 against, 27,721 abstained.
- Preferred frequency of say-on-pay set to one year after 2,535,976 votes for one year.
- Ratification of Marcum LLP as auditor: 5,760,786 for, 109,958 against, 19,128 abstained.
- Total shares outstanding 8,798,829; 66.94% present at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923069896/0001104659-23-069896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923069896/tm2317378d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-069896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer